Impact of DPYD, DPYS, and UPB1 gene variations on severe drug‐related toxicity in patients with cancer

Cancer treatment with a fluoropyrimidine (FP) is often accompanied by severe toxicity that may be dependent on the activity of catalytic enzymes encoded by the DPYD, DPYS, and UPB1 genes. Genotype‐guided dose individualization of FP therapy has been proposed in western countries, but our knowledge o...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoi, Katsuyuki, Nakajima, Yoko, Matsuoka, Hiroshi, Shinkai, Yasuko, Ishihara, Takuma, Maeda, Yasuhiro, Kato, Takema, Katsuno, Hidetoshi, Masumori, Koji, Kawada, Kenji, Yoshikawa, Tetsushi, Ito, Tetsuya, Kurahashi, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469832/
https://www.ncbi.nlm.nih.gov/pubmed/32619063
http://dx.doi.org/10.1111/cas.14553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469832/
https://www.ncbi.nlm.nih.gov/pubmed/32619063
http://dx.doi.org/10.1111/cas.14553

Ejemplares similares